Host-pathogen interplay of Haemophilus ducreyi

Current Opinion in Infectious Diseases

Volumn 23, Issue 1, 2010, Pages 64-69

  Janowicz, Diane M ^a   Li, Wei ^a   Bauer, Margaret E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chancroid; Differential host susceptibility; Haemophilus ducreyi; Human model; Immunopathogenesis

Indexed keywords

BACTERIAL PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PROTEIN LSPA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CLEARANCE; DENDRITIC CELL; DISEASE COURSE; EFFECTOR CELL; GENE IDENTIFICATION; HAEMOPHILUS DUCREYI; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INFECTION SENSITIVITY; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; OUTCOME ASSESSMENT; PHAGOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATOR GENE; REVIEW; SEXUALLY TRANSMITTED DISEASE; SURVIVAL; ULCUS MOLLE;

CHANCROID; HAEMOPHILUS DUCREYI; HOST-PATHOGEN INTERACTIONS; HUMANS;

EID: 74249092659     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328334c0cb     Document Type: Review

References (37)

1. Spinola SM, Wild LM, Apicella MA, et al. Experimental human infection with Haemophilus ducreyi. J Infect Dis 1994; 169:1146-1150.
2. Al-Tawfiq JA, Thornton AC, Katz BP, et al. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis 1998; 178:1684-1687.
3. Bauer ME, Goheen MP, Townsend CA, Spinola SM. Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect Immun 2001; 69:2549-2557.
4. Bauer ME, Townsend CA, Ronald AR, Spinola SM. Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microb Infect 2006; 8:2465-2468.
5. Janowicz DM, OfnerS, Katz BP, Spinola SM. Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience. J Infect Dis 2009; 199:1671-1679.
6. Humphreys TL, Li L, Li X, et al. Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers. Infect Immun 2007; 75:5686-5697.
7. Banks KE, Humphreys TL, Li W, et al. Haemophilus ducreyi partially activates human myeloid dendritic cells. Infect Immun 2007; 75:5678-5685.
8. Li W, Janowicz DM, Fortney KR, et al. Mechanism of human natural killer cell activation by Haemophilus ducreyi. J Infect Dis 2009; 200: 590-598.
9. Spinola SM, Bong CTH, Faber AL, et al. Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection. Infect Immun 2003; 71:6658-6663.
10. Janowicz DM, Fortney KR, Katz BP, et al. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers. Infect Immun 2004; 72:4528-4533.
11. Vakevainen M, Greenberg S, Hansen EJ. Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins. Infect Immun 2003; 71:5994-6003.
12. Mock JR, Vakevainen M, Deng K, et al. Haemophilus ducreyitargets Src family protein tyrosine kinases to inhibit phagocytic signalling. Infect Immun 2005; 73:7808-7816.
13. Deng K, MockJR, Greenberg S, et al. Haemophilus ducreyi LspA proteins are tyrosine phosphorylated by macrophage-encoded protein tyrosine kinases. Infect Immun 2008; 76:4692-4702.
14. Elkins C, Morrow KJ, Olsen B. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA. Infect Immun 2000; 68:1608-1619.
15. Bong CTH, Throm RE, Fortney KR, et al. A DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers. Infect Immun 2001; 69:1488-1491.
16. Abdullah M, Nepluev I, Afonina G, et al. Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding. Infect Immun 2005; 773:3431-3439.
17. Cole LE, Kawula TH, Toffer KL, Elkins C. The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes. Infect Immun 2002; 70:6158-6165.
18. Leduc I, White CD, Nepluev I, et al. Outer membrane protein DsrA is the major fibronectin-binding determinant of Haemophilus ducreyi. Infect Immun 2008; 76:1608-1616.
19. Leduc I, Olsen B, Elkins C. Localization of the domains of the Haemophilus ducreyi trimeric autotransporter DsrA involved in serum resistance and binding to the extracellular matrix proteins fibronectin and vitronectin. Infect Immun 2009; 77:657-666.
20. Bauer ME, Townsend CA, Doster RS, et al. A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans. J Infect Dis 2009; 199:684-692.
21. Whitnack E, Beachey EH. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med 1985; 162:1983-1997.
22. Ringdahl U, Svensson HG, Kotarsky H, et al. A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol 2000; 37:1318-1326.
23. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19:491-511.
24. Mount KLB, Townsend CA, Bauer ME. Haemophilus ducreyi is resistant to human antimicrobial peptides. Antimicrob Agents Chemother 2007; 51:3391-3393.
25. Bauer ME, Fortney KR, Harrison A, et al. Identification of Haemophilus ducreyigenes expressed during human infection. Microbiology 2008; 154:1152-1160.
26. Labandeira-Rey M, Mock JR, Hansen EJ. Regulation of expression of the Haemophilus ducreyi LspB and LspA2 proteins by CpxR. Infect Immun 2009;77:3402-3411.
27. Labandeira-Rey M, Janowicz DM, Blick RJ, et al. Inactivation of the Haemophilus ducreyi luxS gene affects the virulence of this pathogen in human subjects. J Infect Dis 2009; 200:409-416.
28. Spinola SM, Bauer ME, Munson RS Jr. Immunopathogenesis of Haemophilus ducreyi infection (chancroid). Infect Immun 2002; 70:1667-1676.
29. Spinola SM, Orazi A, Arno JN, et al. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis 1996; 173:394-402.
30. Palmer KL, Schnizlein-Bick CT, Orazi A, et al. The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J Infect Dis 1998; 178:1688-1697.
31. Chen C-Y, Mertz KJ, Spinola SM, Morse SA. Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States. J Infect Dis 1997; 175:1390-1395.
32. Janowicz DM, Tenner-Racz K, Racz P, et al. Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication. J Infect Dis 2007; 195:1443-1451.
33. Xu T, Lundqvist A, Ahmed HJ, et al. Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4\+ T cells. Microb Infect 2004; 6:1171-1181.
34. Cooper MA, FehnigerTA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640.
35. Leduc I, Banks KE, Fortney KR, et al. Evaluation of the repertoire of theTonB-dependent receptors of Haemophilus ducreyi for their role in virulence in humans. J Infect Dis 2008; 197:1103-1109.
36. Nepluev I, Afonina G, Fusco WG, et al. An immunogenic surface-exposed domain of Haemophilus ducreyi outer membrane protein HgbA is involved in hemoglobin binding. Infect Immun 2009; 77:3065-3074.
37. Afonina G, Leduc I, Nepluev I, et al. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Infect Immun 2006; 74:2224-2232.